The etiological significance of superantigen in periodontal disease and its possible role

超抗原在牙周病中的病因学意义及其可能的作用

基本信息

  • 批准号:
    10671695
  • 负责人:
  • 金额:
    $ 1.98万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1998
  • 资助国家:
    日本
  • 起止时间:
    1998 至 1999
  • 项目状态:
    已结题

项目摘要

We demonstrated previously that superantigen (SAg) enhances CD80 expression on human monocytes, whereas treatment with SAg in the presence of lipopolysaccharide (LPS) markedly decreases the percentage of CD80ィイD1+ィエD1 peripheral blood monocytes, indicating that the presence of low levels of CD80 on monocytes inhibits CD27 expression on SAg-activated T cells due to insufficient delivery of positive signals via CD28/CD80 interaction. To assess the role of LPS in this inhibition, the relationship between SAg-dependent apoptosis and regulation of CD80 expression of CD14ィイD1+ィエD1 monocytes was examines. SAg enhanced the annexin V-positive or PI-positive (propidium iodide) levels in monocytes, whereas LPS-treated monocytes were resistant to the apoptotic action of SAg. This SAg-induced killing was abrogated by antagonists anti-CD95 (Fas) and anti-CD95 ligand monoclonal antibodies, suggesting a CD95-based pathway of apoptosis. Furthermore, apoptosis of monocytes, preferentially CD80ィイD1-ィエD1 monocytes, was affected by high-level expression of CD95 by SAg, and the survival required down-regulation of CD95 expression by LPS over the SAg action. During these culture periods, the number of CD80ィイD1+ィエD1 monocytes was nearly constant. These observations strongly suggested that a small fraction of CD80ィイD1+ィエD1 monocytes is selectively resistant to CD95-based apoptosis, and the percentage of CD80ィイD1+ィエD1 monocytes increases through escape from SAg-induced preferential apoptosis, which is inhibited by addition of LPS.
我们先前证明超抗原(SAg)增强人单核细胞上的CD 80表达,而在脂多糖(LPS)存在下用SAg处理显著降低外周血单核细胞上的CD 80 β D1+ CD 80 β D1的百分比,表明单核细胞上低水平的CD 80的存在抑制了SAg活化的T细胞上的CD 27表达,这是由于通过CD 28/CD 80的阳性信号传递不足。CD 80相互作用。为了评估LPS在这种抑制中的作用,检测了SAg依赖性细胞凋亡与CD 14 β D1+ CD 80 D1单核细胞表达调节之间的关系。SAg增强了单核细胞中膜联蛋白V阳性或PI阳性(碘化丙啶)的水平,而LPS处理的单核细胞对SAg的凋亡作用具有抗性。这种SAg诱导的杀伤被拮抗剂抗CD 95(Fas)和抗CD 95配体单克隆抗体废除,表明基于CD 95的凋亡途径。此外,单核细胞的凋亡,优先CD 80 CD 95 D1-CD 80 D1单核细胞,受SAg的高水平表达的CD 95的影响,和生存需要下调CD 95的表达由LPS超过SAg的行动。在这些培养期间,CD 80 β D1+ CD 80 β D1单核细胞的数量几乎恒定。这些观察结果强烈表明,一小部分CD 80 β D1+ CD 80 D1单核细胞选择性地抵抗基于CD 95的凋亡,并且CD 80 β D1+ CD 80 D1单核细胞的百分比通过逃避SAg诱导的优先凋亡而增加,这被添加LPS抑制。

项目成果

期刊论文数量(12)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
N.Horiuchi: "Peripheral blood lymphocytes from psoriatic patients are hyporesponsive to β-streptococcal superantigens"Br. J. Dermatol.. 138. 229-235 (1998)
N. Horiuchi:“银屑病患者的外周血淋巴细胞对 β-链球菌超抗原反应低下”Br. J. Dermatol.. 138. 229-235 (1998)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
S.Sugawara: "Heterogeneous expression and release of CD14 by human gingival fibroblast : characterization and CD14-mediated interleukin-8 secretion in response to lipopolysaccharide"Infect. Immun.. 66. 3043-3049 (1998)
S.Sukawara:“人牙龈成纤维细胞 CD14 的异质表达和释放:响应脂多糖的表征和 CD14 介导的白细胞介素 8 分泌”感染。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
N.HORIUCHI: "Peripheral blood lymphocytes from psoriatic patients are hyporesponsive to β-streptococcal superantigens." British Journal of Dermatology. 138(2). 229-235 (1998)
N.HORIUCHI:“银屑病患者的外周血淋巴细胞对 β-链球菌超抗原反应低下。”英国皮肤病学杂志 138(2) (1998)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
S.SUGAWARA: "Heterogeneous expression and release of CD14 by human gingival fibroblasts." Infection and Immunity. 66(7). 3043-3049 (1998)
S.SUGAWARA:“人牙龈成纤维细胞 CD14 的异质表达和释放。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
N. Horiuchi: "Peripheral blood lymphocytes from psoriatic patients are hyporesponsive to β-streptococcal superantigens"Br. J. Dermatol. 138(2). 229-235 (1998)
N. Horiuchi:“银屑病患者的外周血淋巴细胞对 β-链球菌超抗原反应低下”,Br. J. Dermatol,138(2)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RIKIISHI Hidemi其他文献

RIKIISHI Hidemi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RIKIISHI Hidemi', 18)}}的其他基金

Mechanisms of Taxotere-induced apoptosis in or a squamous cell carcinoma.
泰索帝诱导鳞状细胞癌凋亡的机制。
  • 批准号:
    16390577
  • 财政年份:
    2004
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Selective apoptosis during treatment with superantigen and lipopolysaccharide
超抗原和脂多糖治疗期间的选择性细胞凋亡
  • 批准号:
    14571726
  • 财政年份:
    2002
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Inhibition of superantigen-induced apoptosis by LPS
LPS 抑制超抗原诱导的细胞凋亡
  • 批准号:
    12671759
  • 财政年份:
    2000
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Induction of cytokines by oral bacterial stimulation and its arthropathic properties
口腔细菌刺激诱导细胞因子及其关节病特性
  • 批准号:
    02670824
  • 财政年份:
    1990
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似国自然基金

Lipopolysaccharide 调节 Toll-like receptor 4 介导促进心肌样细胞存活时间的实验研究
  • 批准号:
    30872544
  • 批准年份:
    2008
  • 资助金额:
    27.0 万元
  • 项目类别:
    面上项目

相似海外基金

Elucidation of anti-inflammatory mechanism of surface layer protein of lactic acid bacteria focusing on its interaction with lipopolysaccharide.
阐明乳酸菌表面层蛋白的抗炎机制,重点关注其与脂多糖的相互作用。
  • 批准号:
    23K13905
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Pathogenic mechanisms of heart failure induced by the chronic infusion of lipopolysaccharide derived from Porphylomonas gingivalis.
长期输注牙龈卟啉单胞菌脂多糖诱发心力衰竭的致病机制。
  • 批准号:
    23K09517
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Study for recognition of lipopolysaccharide by spike proteins of phage phiX174 using unclear magnetic resonance.
使用不清楚的磁共振研究噬菌体 phiX174 的刺突蛋白识别脂多糖。
  • 批准号:
    23K04941
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Novel roles for lipopolysaccharide modifications in immune evasion
脂多糖修饰在免疫逃避中的新作用
  • 批准号:
    10592139
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
The effects of early adolescent lipopolysaccharide administration on the behaviour of male and female rats through adolescence and adulthood
青春期早期脂多糖给药对雄性和雌性大鼠青春期和成年期行为的影响
  • 批准号:
    548006-2020
  • 财政年份:
    2022
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Mesenchymal inflammatory signaling in regulation of the immune response and tissue dysfunction during lipopolysaccharide-induced acute lung injury
间充质炎症信号在脂多糖诱导的急性肺损伤期间调节免疫反应和组织功能障碍
  • 批准号:
    10389796
  • 财政年份:
    2022
  • 资助金额:
    $ 1.98万
  • 项目类别:
Illuminating the essential role of the outer membrane component and drug target, lipopolysaccharide
阐明外膜成分和药物靶点脂多糖的重要作用
  • 批准号:
    10463261
  • 财政年份:
    2022
  • 资助金额:
    $ 1.98万
  • 项目类别:
Investigation of the effects of intravenous fluid therapy and Imatinib administration in a human intravenous lipopolysaccharide (LPS) model of sepsis.
研究静脉输液疗法和伊马替尼给药对人静脉内脂多糖(LPS)脓毒症模型的影响。
  • 批准号:
    MR/X001660/1
  • 财政年份:
    2022
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Fellowship
Investigating Rickettsia Interspecies and Host-Specific Lipopolysaccharide Variation
研究立克次体种间和宿主特异性脂多糖变异
  • 批准号:
    10628037
  • 财政年份:
    2022
  • 资助金额:
    $ 1.98万
  • 项目类别:
Development of a mechanistically novel Gram-negative antibiotic targeting MsbA-mediated Lipopolysaccharide Biogenesis
开发一种机制新颖的革兰氏阴性抗生素,靶向 MsbA 介导的脂多糖生物发生
  • 批准号:
    10584170
  • 财政年份:
    2022
  • 资助金额:
    $ 1.98万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了